TL;DR: Citrini leveraged Anthropic's Claude to rapidly design hundreds of novel proteins for scorpion antivenom, demonstrating AI's accelerated drug discovery potential.
Summary: Citrini utilized Claude to design 211 novel proteins for a potential scorpion antivenom within 64 hours. Out of these, 17 designs successfully bound to their targets in laboratory tests. This project showcases AI's capability to significantly compress the computational design phase of drug discovery.
Why it matters: This highlights AI's growing role in accelerating complex scientific research and drug development, enabling small teams to achieve significant breakthroughs. AI entrepreneurs should explore applications in computational biology and materials science for rapid prototyping and discovery.
Source: x_com